APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Target Discovery Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Drug Target Discovery Service Market Analysis and Forecast 2026-2032

Report ID 17443093033 July 2026198 pages

Choose your research edition.

Industry ResearchAI Drug Target Discovery Service Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Target Discovery Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal AI Drug Target Discovery Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Target Discovery Service Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Target Discovery Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global AI Drug Target Discovery Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Drug Target Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Drug Target Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Drug Target Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Drug Target Discovery Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Drug Target Discovery Service include Exscientia, Atomwise, Benevolent AI, Insitro, Xaira Therapeutics, Tempus AI, AbCellera, Recursion and Iktos, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Drug Target Discovery Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Drug Target Discovery Service, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Drug Target Discovery Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Drug Target Discovery Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Drug Target Discovery Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Drug Target Discovery Service revenue, projected growth trends, production technology, application and end-user industry.

AI Drug Target Discovery Service Segment by Company

Exscientia

Atomwise

Benevolent AI

Insitro

Xaira Therapeutics

Tempus AI

AbCellera

Recursion

Iktos

Genialis

Anima Biotech

BPGbio

Cradle

Isomorphic Labs

Generate Biomedicines

Latent Labs

Relay Therapeutics

Model Medicines

Nimbus Therapeutics

Schrödinger

XtalPi

Insilico Medicine

Drug Farm

BioMap

AI Drug Target Discovery Service Segment by Type

Target Identification Based on Omics Data and Biological Networks

Target Mining Based on Literature and Knowledge Graphs

Target Prediction Based on Structural Bioinformatics

Target Discovery Based on Phenotypic Screening and Virtual Patients

AI Drug Target Discovery Service Segment by Application

Pharmaceutical Company

CRO and Universities

Others

AI Drug Target Discovery Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Target Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Target Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Target Discovery Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Drug Target Discovery Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Drug Target Discovery Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Target Discovery Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Drug Target Discovery Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Target Identification Based on Omics Data and Biological Networks Major Player Table 3. Target Mining Based on Literature and Knowledge Graphs Major Player Table 4. Target Prediction Based on Structural Bioinformatics Major Player Table 5. Target Discovery Based on Phenotypic Screening and Virtual Patients Major Player Table 6. Global AI Drug Target Discovery Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Company Major Player Table 8. CRO and Universities Major Player Table 9. Others Major Player Table 10. AI Drug Target Discovery Service Industry Trends Table 11. AI Drug Target Discovery Service Industry Drivers Table 12. AI Drug Target Discovery Service Industry Opportunities and Challenges Table 13. AI Drug Target Discovery Service Industry Restraints Table 14. Global AI Drug Target Discovery Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global AI Drug Target Discovery Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global AI Drug Target Discovery Service Market Share by Region (2021-2026) Table 17. Global AI Drug Target Discovery Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global AI Drug Target Discovery Service Market Share by Region (2027-2032) Table 19. Global AI Drug Target Discovery Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global AI Drug Target Discovery Service Revenue Market Share by Players (2021-2026) Table 21. Global AI Drug Target Discovery Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global AI Drug Target Discovery Service Key Players Headquarters & Area Served Table 23. Global AI Drug Target Discovery Service Players, Product Type & Application Table 24. Global AI Drug Target Discovery Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global AI Drug Target Discovery Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global AI Drug Target Discovery Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AI Drug Target Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global AI Drug Target Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global AI Drug Target Discovery Service Revenue Market Share by Type (2021-2026) Table 31. Global AI Drug Target Discovery Service Revenue Market Share by Type (2027-2032) Table 32. Global AI Drug Target Discovery Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI Drug Target Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global AI Drug Target Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global AI Drug Target Discovery Service Revenue Market Share by Application (2021-2026) Table 36. Global AI Drug Target Discovery Service Revenue Market Share by Application (2027-2032) Table 37. Exscientia Company Information Table 38. Exscientia Business Overview Table 39. Exscientia AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Exscientia AI Drug Target Discovery Service Product Portfolio Table 41. Exscientia Recent Development Table 42. Atomwise Company Information Table 43. Atomwise Business Overview Table 44. Atomwise AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Atomwise AI Drug Target Discovery Service Product Portfolio Table 46. Atomwise Recent Development Table 47. Benevolent AI Company Information Table 48. Benevolent AI Business Overview Table 49. Benevolent AI AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Benevolent AI AI Drug Target Discovery Service Product Portfolio Table 51. Benevolent AI Recent Development Table 52. Insitro Company Information Table 53. Insitro Business Overview Table 54. Insitro AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Insitro AI Drug Target Discovery Service Product Portfolio Table 56. Insitro Recent Development Table 57. Xaira Therapeutics Company Information Table 58. Xaira Therapeutics Business Overview Table 59. Xaira Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Xaira Therapeutics AI Drug Target Discovery Service Product Portfolio Table 61. Xaira Therapeutics Recent Development Table 62. Tempus AI Company Information Table 63. Tempus AI Business Overview Table 64. Tempus AI AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Tempus AI AI Drug Target Discovery Service Product Portfolio Table 66. Tempus AI Recent Development Table 67. AbCellera Company Information Table 68. AbCellera Business Overview Table 69. AbCellera AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. AbCellera AI Drug Target Discovery Service Product Portfolio Table 71. AbCellera Recent Development Table 72. Recursion Company Information Table 73. Recursion Business Overview Table 74. Recursion AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Recursion AI Drug Target Discovery Service Product Portfolio Table 76. Recursion Recent Development Table 77. Iktos Company Information Table 78. Iktos Business Overview Table 79. Iktos AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Iktos AI Drug Target Discovery Service Product Portfolio Table 81. Iktos Recent Development Table 82. Genialis Company Information Table 83. Genialis Business Overview Table 84. Genialis AI Drug Target Discovery Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Genialis AI Drug Target Discovery Service Product Portfolio Table 86. Genialis Recent Development Table 87. Anima Biotech Company Information Table 88. Anima Biotech Business Overview Table 89. Anima Biotech AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Anima Biotech AI Drug Target Discovery Service Product Portfolio Table 91. Anima Biotech Recent Development Table 92. BPGbio Company Information Table 93. BPGbio Business Overview Table 94. BPGbio AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. BPGbio AI Drug Target Discovery Service Product Portfolio Table 96. BPGbio Recent Development Table 97. Cradle Company Information Table 98. Cradle Business Overview Table 99. Cradle AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Cradle AI Drug Target Discovery Service Product Portfolio Table 101. Cradle Recent Development Table 102. Isomorphic Labs Company Information Table 103. Isomorphic Labs Business Overview Table 104. Isomorphic Labs AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Isomorphic Labs AI Drug Target Discovery Service Product Portfolio Table 106. Isomorphic Labs Recent Development Table 107. Generate Biomedicines Company Information Table 108. Generate Biomedicines Business Overview Table 109. Generate Biomedicines AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Generate Biomedicines AI Drug Target Discovery Service Product Portfolio Table 111. Generate Biomedicines Recent Development Table 112. Latent Labs Company Information Table 113. Latent Labs Business Overview Table 114. Latent Labs AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Latent Labs AI Drug Target Discovery Service Product Portfolio Table 116. Latent Labs Recent Development Table 117. Relay Therapeutics Company Information Table 118. Relay Therapeutics Business Overview Table 119. Relay Therapeutics AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Relay Therapeutics AI Drug Target Discovery Service Product Portfolio Table 121. Relay Therapeutics Recent Development Table 122. Model Medicines Company Information Table 123. Model Medicines Business Overview Table 124. Model Medicines AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Model Medicines AI Drug Target Discovery Service Product Portfolio Table 126. Model Medicines Recent Development Table 127. Nimbus Therapeutics Company Information Table 128. Nimbus Therapeutics Business Overview Table 129. Nimbus Therapeutics AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Nimbus Therapeutics AI Drug Target Discovery Service Product Portfolio Table 131. Nimbus Therapeutics Recent Development Table 132. Schrödinger Company Information Table 133. Schrödinger Business Overview Table 134. Schrödinger AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Schrödinger AI Drug Target Discovery Service Product Portfolio Table 136. Schrödinger Recent Development Table 137. XtalPi Company Information Table 138. XtalPi Business Overview Table 139. XtalPi AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. XtalPi AI Drug Target Discovery Service Product Portfolio Table 141. XtalPi Recent Development Table 142. Insilico Medicine Company Information Table 143. Insilico Medicine Business Overview Table 144. Insilico Medicine AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Insilico Medicine AI Drug Target Discovery Service Product Portfolio Table 146. Insilico Medicine Recent Development Table 147. Drug Farm Company Information Table 148. Drug Farm Business Overview Table 149. Drug Farm AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Drug Farm AI Drug Target Discovery Service Product Portfolio Table 151. Drug Farm Recent Development Table 152. BioMap Company Information Table 153. BioMap Business Overview Table 154. BioMap AI Drug Target Discovery Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. BioMap AI Drug Target Discovery Service Product Portfolio Table 156. BioMap Recent Development Table 157. North America AI Drug Target Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 158. North America AI Drug Target Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 159. North America AI Drug Target Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 160. North America AI Drug Target Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 161. North America AI Drug Target Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. North America AI Drug Target Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 163. North America AI Drug Target Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 164. Europe AI Drug Target Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe AI Drug Target Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe AI Drug Target Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 167. Europe AI Drug Target Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 168. Europe AI Drug Target Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Europe AI Drug Target Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 170. Europe AI Drug Target Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 171. China AI Drug Target Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 172. China AI Drug Target Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 173. China AI Drug Target Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 174. China AI Drug Target Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia AI Drug Target Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 176. Asia AI Drug Target Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 177. Asia AI Drug Target Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia AI Drug Target Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia AI Drug Target Discovery Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia AI Drug Target Discovery Service Revenue by Region (US$ Million) & (2021-2026) Table 181. Asia AI Drug Target Discovery Service Revenue by Region (US$ Million) & (2027-2032) Table 182. SAMEA AI Drug Target Discovery Service Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA AI Drug Target Discovery Service Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA AI Drug Target Discovery Service Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA AI Drug Target Discovery Service Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA AI Drug Target Discovery Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. SAMEA AI Drug Target Discovery Service Revenue by Country (2021-2026) & (US$ Million) Table 188. SAMEA AI Drug Target Discovery Service Revenue by Country (US$ Million) & (2027-2032) Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. AI Drug Target Discovery Service Image Figure 2. Global AI Drug Target Discovery Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Target Discovery Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Target Identification Based on Omics Data and Biological Networks Image Figure 5. Target Mining Based on Literature and Knowledge Graphs Image Figure 6. Target Prediction Based on Structural Bioinformatics Image Figure 7. Target Discovery Based on Phenotypic Screening and Virtual Patients Image Figure 8. Global AI Drug Target Discovery Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global AI Drug Target Discovery Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Company Image Figure 11. CRO and Universities Image Figure 12. Others Image Figure 13. Global AI Drug Target Discovery Service Market Size (US$ Million) & (2021-2032) Figure 14. Global AI Drug Target Discovery Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global AI Drug Target Discovery Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global AI Drug Target Discovery Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global AI Drug Target Discovery Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI Drug Target Discovery Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global AI Drug Target Discovery Service Revenue Market Share by Type (2021-2032) Figure 21. Global AI Drug Target Discovery Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI Drug Target Discovery Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global AI Drug Target Discovery Service Revenue Market Share by Application (2021-2032) Figure 24. North America AI Drug Target Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America AI Drug Target Discovery Service Revenue Share by Type (2021-2032) Figure 26. North America AI Drug Target Discovery Service Revenue Share by Application (2021-2032) Figure 27. North America AI Drug Target Discovery Service Revenue Share by Country (2021-2032) Figure 28. United States AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe AI Drug Target Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe AI Drug Target Discovery Service Revenue Share by Type (2021-2032) Figure 33. Europe AI Drug Target Discovery Service Revenue Share by Application (2021-2032) Figure 34. Europe AI Drug Target Discovery Service Revenue Share by Country (2021-2032) Figure 35. Germany AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China AI Drug Target Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China AI Drug Target Discovery Service Revenue Share by Type (2021-2032) Figure 45. China AI Drug Target Discovery Service Revenue Share by Application (2021-2032) Figure 46. Asia AI Drug Target Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia AI Drug Target Discovery Service Revenue Share by Type (2021-2032) Figure 48. Asia AI Drug Target Discovery Service Revenue Share by Application (2021-2032) Figure 49. Asia AI Drug Target Discovery Service Revenue Share by Region (2021-2032) Figure 50. Japan AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA AI Drug Target Discovery Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA AI Drug Target Discovery Service Revenue Share by Type (2021-2032) Figure 58. SAMEA AI Drug Target Discovery Service Revenue Share by Application (2021-2032) Figure 59. SAMEA AI Drug Target Discovery Service Revenue Share by Country (2021-2032) Figure 60. Brazil AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt AI Drug Target Discovery Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Target Identification Based on Omics Data and Biological Networks
  • Target Mining Based on Literature and Knowledge Graphs
  • Target Prediction Based on Structural Bioinformatics
  • Target Discovery Based on Phenotypic Screening and Virtual Patients
Applications
  • Pharmaceutical Company
  • CRO and Universities
  • Others
Companies covered
  • Exscientia
  • Atomwise
  • Benevolent AI
  • Insitro
  • Xaira Therapeutics
  • Tempus AI
  • AbCellera
  • Recursion
  • Iktos
  • Genialis
  • Anima Biotech
  • BPGbio
  • Cradle
  • Isomorphic Labs
  • Generate Biomedicines
  • Latent Labs
  • Relay Therapeutics
  • Model Medicines
  • Nimbus Therapeutics
  • Schrödinger
  • XtalPi
  • Insilico Medicine
  • Drug Farm
  • BioMap

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Drug Target Discovery Service Market by Type
  3. 1.2.1 Global AI Drug Target Discovery Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Target Identification Based on Omics Data and Biological Networks
  5. 1.2.3 Target Mining Based on Literature and Knowledge Graphs
  6. 1.2.4 Target Prediction Based on Structural Bioinformatics
  7. 1.2.5 Target Discovery Based on Phenotypic Screening and Virtual Patients
  8. 1.3 AI Drug Target Discovery Service Market by Application
  9. 1.3.1 Global AI Drug Target Discovery Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Company
  11. 1.3.3 CRO and Universities
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 AI Drug Target Discovery Service Market Dynamics
  1. 2.1 AI Drug Target Discovery Service Industry Trends
  2. 2.2 AI Drug Target Discovery Service Industry Drivers
  3. 2.3 AI Drug Target Discovery Service Industry Opportunities and Challenges
  4. 2.4 AI Drug Target Discovery Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Drug Target Discovery Service Market Perspective (2021-2032)
  2. 3.2 Global AI Drug Target Discovery Service Growth Trends by Region
  3. 3.2.1 Global AI Drug Target Discovery Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Drug Target Discovery Service Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Drug Target Discovery Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Drug Target Discovery Service Revenue by Players
  2. 4.1.1 Global AI Drug Target Discovery Service Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Drug Target Discovery Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Drug Target Discovery Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Drug Target Discovery Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Drug Target Discovery Service Key Players Headquarters & Area Served
  7. 4.4 Global AI Drug Target Discovery Service Players, Product Type & Application
  8. 4.5 Global AI Drug Target Discovery Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Drug Target Discovery Service Market CR5 and HHI
  11. 4.6.3 2025 AI Drug Target Discovery Service Tier 1, Tier 2, and Tier 3
5 AI Drug Target Discovery Service Market Size by Type
  1. 5.1 Global AI Drug Target Discovery Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Drug Target Discovery Service Revenue by Type (2021-2032)
  3. 5.3 Global AI Drug Target Discovery Service Revenue Market Share by Type (2021-2032)
6 AI Drug Target Discovery Service Market Size by Application
  1. 6.1 Global AI Drug Target Discovery Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Drug Target Discovery Service Revenue by Application (2021-2032)
  3. 6.3 Global AI Drug Target Discovery Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Exscientia
  2. 7.1.1 Exscientia Company Information
  3. 7.1.2 Exscientia Business Overview
  4. 7.1.3 Exscientia AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Exscientia AI Drug Target Discovery Service Product Portfolio
  6. 7.1.5 Exscientia Recent Developments
  7. 7.2 Atomwise
  8. 7.2.1 Atomwise Company Information
  9. 7.2.2 Atomwise Business Overview
  10. 7.2.3 Atomwise AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Atomwise AI Drug Target Discovery Service Product Portfolio
  12. 7.2.5 Atomwise Recent Developments
  13. 7.3 Benevolent AI
  14. 7.3.1 Benevolent AI Company Information
  15. 7.3.2 Benevolent AI Business Overview
  16. 7.3.3 Benevolent AI AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Benevolent AI AI Drug Target Discovery Service Product Portfolio
  18. 7.3.5 Benevolent AI Recent Developments
  19. 7.4 Insitro
  20. 7.4.1 Insitro Company Information
  21. 7.4.2 Insitro Business Overview
  22. 7.4.3 Insitro AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Insitro AI Drug Target Discovery Service Product Portfolio
  24. 7.4.5 Insitro Recent Developments
  25. 7.5 Xaira Therapeutics
  26. 7.5.1 Xaira Therapeutics Company Information
  27. 7.5.2 Xaira Therapeutics Business Overview
  28. 7.5.3 Xaira Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Xaira Therapeutics AI Drug Target Discovery Service Product Portfolio
  30. 7.5.5 Xaira Therapeutics Recent Developments
  31. 7.6 Tempus AI
  32. 7.6.1 Tempus AI Company Information
  33. 7.6.2 Tempus AI Business Overview
  34. 7.6.3 Tempus AI AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Tempus AI AI Drug Target Discovery Service Product Portfolio
  36. 7.6.5 Tempus AI Recent Developments
  37. 7.7 AbCellera
  38. 7.7.1 AbCellera Company Information
  39. 7.7.2 AbCellera Business Overview
  40. 7.7.3 AbCellera AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AbCellera AI Drug Target Discovery Service Product Portfolio
  42. 7.7.5 AbCellera Recent Developments
  43. 7.8 Recursion
  44. 7.8.1 Recursion Company Information
  45. 7.8.2 Recursion Business Overview
  46. 7.8.3 Recursion AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Recursion AI Drug Target Discovery Service Product Portfolio
  48. 7.8.5 Recursion Recent Developments
  49. 7.9 Iktos
  50. 7.9.1 Iktos Company Information
  51. 7.9.2 Iktos Business Overview
  52. 7.9.3 Iktos AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Iktos AI Drug Target Discovery Service Product Portfolio
  54. 7.9.5 Iktos Recent Developments
  55. 7.10 Genialis
  56. 7.10.1 Genialis Company Information
  57. 7.10.2 Genialis Business Overview
  58. 7.10.3 Genialis AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Genialis AI Drug Target Discovery Service Product Portfolio
  60. 7.10.5 Genialis Recent Developments
  61. 7.11 Anima Biotech
  62. 7.11.1 Anima Biotech Company Information
  63. 7.11.2 Anima Biotech Business Overview
  64. 7.11.3 Anima Biotech AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Anima Biotech AI Drug Target Discovery Service Product Portfolio
  66. 7.11.5 Anima Biotech Recent Developments
  67. 7.12 BPGbio
  68. 7.12.1 BPGbio Company Information
  69. 7.12.2 BPGbio Business Overview
  70. 7.12.3 BPGbio AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 BPGbio AI Drug Target Discovery Service Product Portfolio
  72. 7.12.5 BPGbio Recent Developments
  73. 7.13 Cradle
  74. 7.13.1 Cradle Company Information
  75. 7.13.2 Cradle Business Overview
  76. 7.13.3 Cradle AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cradle AI Drug Target Discovery Service Product Portfolio
  78. 7.13.5 Cradle Recent Developments
  79. 7.14 Isomorphic Labs
  80. 7.14.1 Isomorphic Labs Company Information
  81. 7.14.2 Isomorphic Labs Business Overview
  82. 7.14.3 Isomorphic Labs AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Isomorphic Labs AI Drug Target Discovery Service Product Portfolio
  84. 7.14.5 Isomorphic Labs Recent Developments
  85. 7.15 Generate Biomedicines
  86. 7.15.1 Generate Biomedicines Company Information
  87. 7.15.2 Generate Biomedicines Business Overview
  88. 7.15.3 Generate Biomedicines AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Generate Biomedicines AI Drug Target Discovery Service Product Portfolio
  90. 7.15.5 Generate Biomedicines Recent Developments
  91. 7.16 Latent Labs
  92. 7.16.1 Latent Labs Company Information
  93. 7.16.2 Latent Labs Business Overview
  94. 7.16.3 Latent Labs AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Latent Labs AI Drug Target Discovery Service Product Portfolio
  96. 7.16.5 Latent Labs Recent Developments
  97. 7.17 Relay Therapeutics
  98. 7.17.1 Relay Therapeutics Company Information
  99. 7.17.2 Relay Therapeutics Business Overview
  100. 7.17.3 Relay Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Relay Therapeutics AI Drug Target Discovery Service Product Portfolio
  102. 7.17.5 Relay Therapeutics Recent Developments
  103. 7.18 Model Medicines
  104. 7.18.1 Model Medicines Company Information
  105. 7.18.2 Model Medicines Business Overview
  106. 7.18.3 Model Medicines AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Model Medicines AI Drug Target Discovery Service Product Portfolio
  108. 7.18.5 Model Medicines Recent Developments
  109. 7.19 Nimbus Therapeutics
  110. 7.19.1 Nimbus Therapeutics Company Information
  111. 7.19.2 Nimbus Therapeutics Business Overview
  112. 7.19.3 Nimbus Therapeutics AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Nimbus Therapeutics AI Drug Target Discovery Service Product Portfolio
  114. 7.19.5 Nimbus Therapeutics Recent Developments
  115. 7.20 Schrödinger
  116. 7.20.1 Schrödinger Company Information
  117. 7.20.2 Schrödinger Business Overview
  118. 7.20.3 Schrödinger AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Schrödinger AI Drug Target Discovery Service Product Portfolio
  120. 7.20.5 Schrödinger Recent Developments
  121. 7.21 XtalPi
  122. 7.21.1 XtalPi Company Information
  123. 7.21.2 XtalPi Business Overview
  124. 7.21.3 XtalPi AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 XtalPi AI Drug Target Discovery Service Product Portfolio
  126. 7.21.5 XtalPi Recent Developments
  127. 7.22 Insilico Medicine
  128. 7.22.1 Insilico Medicine Company Information
  129. 7.22.2 Insilico Medicine Business Overview
  130. 7.22.3 Insilico Medicine AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Insilico Medicine AI Drug Target Discovery Service Product Portfolio
  132. 7.22.5 Insilico Medicine Recent Developments
  133. 7.23 Drug Farm
  134. 7.23.1 Drug Farm Company Information
  135. 7.23.2 Drug Farm Business Overview
  136. 7.23.3 Drug Farm AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Drug Farm AI Drug Target Discovery Service Product Portfolio
  138. 7.23.5 Drug Farm Recent Developments
  139. 7.24 BioMap
  140. 7.24.1 BioMap Company Information
  141. 7.24.2 BioMap Business Overview
  142. 7.24.3 BioMap AI Drug Target Discovery Service Revenue and Gross Margin (2021-2026)
  143. 7.24.4 BioMap AI Drug Target Discovery Service Product Portfolio
  144. 7.24.5 BioMap Recent Developments
8 North America
  1. 8.1 North America AI Drug Target Discovery Service Revenue (2021-2032)
  2. 8.2 North America AI Drug Target Discovery Service Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Drug Target Discovery Service Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Drug Target Discovery Service Revenue by Type (2027-2032)
  5. 8.3 North America AI Drug Target Discovery Service Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Drug Target Discovery Service Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Drug Target Discovery Service Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Drug Target Discovery Service Revenue by Application (2027-2032)
  9. 8.5 North America AI Drug Target Discovery Service Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Drug Target Discovery Service Revenue by Country
  11. 8.6.1 North America AI Drug Target Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Drug Target Discovery Service Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Drug Target Discovery Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Drug Target Discovery Service Revenue (2021-2032)
  2. 9.2 Europe AI Drug Target Discovery Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Drug Target Discovery Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Drug Target Discovery Service Revenue by Type (2027-2032)
  5. 9.3 Europe AI Drug Target Discovery Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Drug Target Discovery Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Drug Target Discovery Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Drug Target Discovery Service Revenue by Application (2027-2032)
  9. 9.5 Europe AI Drug Target Discovery Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Drug Target Discovery Service Revenue by Country
  11. 9.6.1 Europe AI Drug Target Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Drug Target Discovery Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Drug Target Discovery Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Drug Target Discovery Service Revenue (2021-2032)
  2. 10.2 China AI Drug Target Discovery Service Revenue by Type (2021-2032)
  3. 10.2.1 China AI Drug Target Discovery Service Revenue by Type (2021-2026)
  4. 10.2.2 China AI Drug Target Discovery Service Revenue by Type (2027-2032)
  5. 10.3 China AI Drug Target Discovery Service Revenue Share by Type (2021-2032)
  6. 10.4 China AI Drug Target Discovery Service Revenue by Application (2021-2032)
  7. 10.4.1 China AI Drug Target Discovery Service Revenue by Application (2021-2026)
  8. 10.4.2 China AI Drug Target Discovery Service Revenue by Application (2027-2032)
  9. 10.5 China AI Drug Target Discovery Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Drug Target Discovery Service Revenue (2021-2032)
  2. 11.2 Asia AI Drug Target Discovery Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Drug Target Discovery Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Drug Target Discovery Service Revenue by Type (2027-2032)
  5. 11.3 Asia AI Drug Target Discovery Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Drug Target Discovery Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Drug Target Discovery Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Drug Target Discovery Service Revenue by Application (2027-2032)
  9. 11.5 Asia AI Drug Target Discovery Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Drug Target Discovery Service Revenue by Country
  11. 11.6.1 Asia AI Drug Target Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Drug Target Discovery Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Drug Target Discovery Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Drug Target Discovery Service Revenue (2021-2032)
  2. 12.2 SAMEA AI Drug Target Discovery Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Drug Target Discovery Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Drug Target Discovery Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Drug Target Discovery Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Drug Target Discovery Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Drug Target Discovery Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Drug Target Discovery Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Drug Target Discovery Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Drug Target Discovery Service Revenue by Country
  11. 12.6.1 SAMEA AI Drug Target Discovery Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Drug Target Discovery Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Drug Target Discovery Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst